Merck & Co. Inc. | Cash Flow
Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
4,517
11,934
4,459
3,941
2,418
6,193
Depreciation, Depletion & Amortization
6,988
6,691
6,375
5,441
4,637
4,519
Other Funds
60
131
61
118
195
2,272
Funds from Operations
12,448
6,036
12,806
12,977
11,468
12,475
Changes in Working Capital
794
1,824
268
2,601
5,021
1,553
Net Operating Cash Flow
11,654
7,860
12,538
10,376
6,447
10,922
Capital Expenditures
1,548
1,317
1,283
1,614
1,888
Sale of Fixed Assets & Businesses
46
15,120
316
-
-
Purchase/Sale of Investments
1,693
9,830
3,732
1,298
4,925
Net Investing Cash Flow
3,148
374
4,758
3,210
2,679
Cash Dividends Paid - Total
5,157
5,170
5,117
5,124
5,167
Issuance/Reduction of Debt, Net
4,533
3,931
3,492
1,307
1,129
Net Financing Cash Flow
5,990
15,113
5,387
9,044
10,006
Net Change in Cash
2,170
8,180
1,083
2,009
423
Free Cash Flow
10,106
6,543
11,255
8,762
4,559
Deferred Taxes & Investment Tax Credit
330
2,600
764
1,521
2,621
509
Net Assets from Acquisitions
246
4,881
7,744
780
396
Other Sources
350
614
221
482
38
Change in Capital Stock
5,306
6,143
3,701
2,495
3,515
Exchange Rate Effect
346
553
1,310
131
457
About Merck & Co.
View Profile
